# Byooviz

NDC: 64406-019
Generic name: ranibizumab-nuna
Labeler / Manufacturer: BIOGEN INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVITREAL
Marketing started: 20220601
Marketing ended: 20280719
FDA application: BLA761202

## Active ingredients

- RANIBIZUMAB: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64406-019"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64406-019
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e46db299-edd1-4457-89b2-c1e2e505f1b0